Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bob Olsson

Showing results (41-50 of 80) with videos related to

Pageof 8
Sort By:
Acta Neurologica Scandinavica|May 16, 2019
Cerebrospinal fluid biomarkers in patients with neurological symptoms but without neurological diseasesRadu Constantinescu, Ubah Mahamud, Clara Constantinescu, et al.
Metabolism: Clinical and Experimental|December 9, 2008
Changes in adipose tissue gene expression and plasma levels of adipokines and acute-phase proteins in patients with critical illnessMargareta Jernås, Bob Olsson, Kajsa Sjöholm, et al.
Plos One|May 26, 2011
Establishment of a transgenic mouse model specifically expressing human serum amyloid A in adipose tissueMaja Olsson, Sofie Ahlin, Bob Olsson, et al.
Annals of Clinical and Translational Neurology|August 12, 2020
Comparing progression biomarkers in clinical trials of early Alzheimer's diseaseNicholas C Cullen, Henrik Zetterberg, Philip S Insel, et al.
Endocrinology|November 13, 2004
Bovine growth hormone transgenic mice are resistant to diet-induced obesity but develop hyperphagia, dyslipidemia, and diabetes on a high-fat dietBob Olsson, Mohammad Bohlooly-Y, Sharyn M Fitzgerald, et al.
American Journal of Physiology. Endocrinology and Metabolism|May 9, 2003
Bovine growth hormone-transgenic mice have major alterations in hepatic expression of metabolic genesBob Olsson, Mohammad Bohlooly-Y, Ola Brusehed, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 17, 2013
Imatinib treatment and Aβ42 in humansBob Olsson, Laurence Legros, François Guilhot, et al.
JAMA Neurology|August 11, 2015
Cerebrospinal Fluid Patterns and the Risk of Future Dementia in Early, Incident Parkinson DiseaseDavid C Bäckström, Magdalena Eriksson Domellöf, Jan Linder, et al.
Metabolism: Clinical and Experimental|July 13, 2010
Expression of the selenoprotein S (SELS) gene in subcutaneous adipose tissue and SELS genotype are associated with metabolic risk factorsMaja Olsson, Bob Olsson, Peter Jacobson, et al.
The Journal of Endocrinology|August 25, 2012
Local overexpression of GH and GH/IGF1 effects in the adult mouse hippocampusMarion Walser, Maria Teresa Samà, Ruth Wickelgren, et al.
Pageof 8

Showing results (41-50 of 80) with videos related to

Sort By:
Pageof 8
Acta Neurologica Scandinavica|May 16, 2019
Cerebrospinal fluid biomarkers in patients with neurological symptoms but without neurological diseasesRadu Constantinescu, Ubah Mahamud, Clara Constantinescu, et al.
Metabolism: Clinical and Experimental|December 9, 2008
Changes in adipose tissue gene expression and plasma levels of adipokines and acute-phase proteins in patients with critical illnessMargareta Jernås, Bob Olsson, Kajsa Sjöholm, et al.
Plos One|May 26, 2011
Establishment of a transgenic mouse model specifically expressing human serum amyloid A in adipose tissueMaja Olsson, Sofie Ahlin, Bob Olsson, et al.
Annals of Clinical and Translational Neurology|August 12, 2020
Comparing progression biomarkers in clinical trials of early Alzheimer's diseaseNicholas C Cullen, Henrik Zetterberg, Philip S Insel, et al.
Endocrinology|November 13, 2004
Bovine growth hormone transgenic mice are resistant to diet-induced obesity but develop hyperphagia, dyslipidemia, and diabetes on a high-fat dietBob Olsson, Mohammad Bohlooly-Y, Sharyn M Fitzgerald, et al.
American Journal of Physiology. Endocrinology and Metabolism|May 9, 2003
Bovine growth hormone-transgenic mice have major alterations in hepatic expression of metabolic genesBob Olsson, Mohammad Bohlooly-Y, Ola Brusehed, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 17, 2013
Imatinib treatment and Aβ42 in humansBob Olsson, Laurence Legros, François Guilhot, et al.
JAMA Neurology|August 11, 2015
Cerebrospinal Fluid Patterns and the Risk of Future Dementia in Early, Incident Parkinson DiseaseDavid C Bäckström, Magdalena Eriksson Domellöf, Jan Linder, et al.
Metabolism: Clinical and Experimental|July 13, 2010
Expression of the selenoprotein S (SELS) gene in subcutaneous adipose tissue and SELS genotype are associated with metabolic risk factorsMaja Olsson, Bob Olsson, Peter Jacobson, et al.
The Journal of Endocrinology|August 25, 2012
Local overexpression of GH and GH/IGF1 effects in the adult mouse hippocampusMarion Walser, Maria Teresa Samà, Ruth Wickelgren, et al.
Pageof 8